10:39 AM EDT, 04/04/2024 (MT Newswires) -- Scott Bizily, Chief Legal Officer, on April 01, 2024, sold 8,153 shares in 4D Molecular Therapeutics ( FDMT ) for $259,102. Following the Form 4 filing with the SEC, Bizily has control over a total of 1,737 shares of the company, with 1,737 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650648/000095017024041418/xslF345X03/ownership.xml

Price: 28.44, Change: +0.52, Percent Change: +1.86